ロード中...
Minimal Residual Disease in Acute Myeloid Leukemia
Technological advances in the laboratory have lead to substantial improvements in clinical decision-making by the use of pre-treatment prognostic risk stratification factors in acute myeloid leukemia (AML). Unfortunately similar progress has not been made in treatment response criteria, with the def...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4163748/ https://ncbi.nlm.nih.gov/pubmed/23799371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.100 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|